» Articles » PMID: 27384475

Thyroid Hormone Synthesis: a Potential Target of a Chinese Herbal Formula Haizao Yuhu Decoction Acting on Iodine-deficient Goiter

Overview
Journal Oncotarget
Specialty Oncology
Date 2016 Jul 8
PMID 27384475
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Haizao Yuhu Decoction (HYD), a famous multi-component herbal formula, has been widely used to treat various thyroid-related diseases, including iodine-deficient goiter. Herb pair Thallus Sargassi Pallidi (HZ) and Radix Glycyrrhizae (GC), one of the so-called "eighteen antagonistic medicaments", contains in HYD. To explore pharmacological mechanisms of HYD acting on iodine-deficient goiter and to provide evidence for potential roles of herb pair HZ and GC in HYD, our genome-wide microarray detection and network analysis identified a list of goiter-related genes, mainly involved into the alterations in hypothalamus-pituitary-thyroid/gonad/growth axes. Then, the disease genes-drug genes interaction network illustrated the links between HYD regulating genes and goiter-related genes, and identified the candidate targets of HYD acting on goiter. Functionally, these candidate targets were closely correlated with thyroid hormone synthesis. Moreover, the potential regulating genes of herb pair HZ and GC were revealed to be crucial components in the pathway of thyroid hormone synthesis. The prediction results were all verified by following experiments based on goiter rats. Collectively, this integrative study combining microarray gene expression profiling, network analysis and experimental validations offers the convincing evidence that HYD may alleviate iodine-deficient goiter via regulating thyroid hormone synthesis, and explains the necessity of herb pair HZ and GC in HYD. Our work provides a novel and powerful means to clarify the mechanisms of action for multi-component drugs such as herbal formulae in a holistic way, which may improve drug development and applications.

Citing Articles

Mechanism of Sophorae Flavescentis Radix against ovarian cancer via new pharmacology, molecular docking, and experimental verification.

Fu X, Liang F Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(9):6837-6850.

PMID: 38561549 DOI: 10.1007/s00210-024-03065-z.


Network Pharmacology, Molecular Docking, and Experimental Validation to Unveil the Molecular Targets and Mechanisms of Compound Fuling Granule to Treat Ovarian Cancer.

Li Z, Liu Q, Zhu Y, Wu L, Liu W, Li J Oxid Med Cell Longev. 2022; 2022:2896049.

PMID: 36062197 PMC: 9428684. DOI: 10.1155/2022/2896049.


Network pharmacology-based predictions of active components and pharmacological mechanisms of Artemisia annua L. for the treatment of the novel Corona virus disease 2019 (COVID-19).

Tang Y, Li X, Yuan Y, Zhang H, Zou Y, Xu Z BMC Complement Med Ther. 2022; 22(1):56.

PMID: 35241045 PMC: 8893058. DOI: 10.1186/s12906-022-03523-2.


Investigation of anti-osteoporosis mechanisms of Rehmanniae Radix Preparata based on network pharmacology and experimental verification.

Ou L, Kang W, Liang Z, Gao F, Dong T, Wei P J Orthop Surg Res. 2021; 16(1):599.

PMID: 34649566 PMC: 8515747. DOI: 10.1186/s13018-021-02751-5.


Prescription of Relieved Goiter through Promoted Apoptosis of Thyroid Cells via miR-511-3p and PTEN/PI3K/Akt Pathway.

Deng Y, Chen S, Wang H, Wang B, Xiao K J Healthc Eng. 2021; 2021:3506559.

PMID: 34630982 PMC: 8494543. DOI: 10.1155/2021/3506559.


References
1.
Zhao W, Han C, Shi X, Xiong C, Sun J, Shan Z . Prevalence of goiter and thyroid nodules before and after implementation of the universal salt iodization program in mainland China from 1985 to 2014: a systematic review and meta-analysis. PLoS One. 2014; 9(10):e109549. PMC: 4196906. DOI: 10.1371/journal.pone.0109549. View

2.
Hopkins A . Network pharmacology. Nat Biotechnol. 2007; 25(10):1110-1. DOI: 10.1038/nbt1007-1110. View

3.
Ballester M, Castello A, Ibanez E, Sanchez A, Folch J . Real-time quantitative PCR-based system for determining transgene copy number in transgenic animals. Biotechniques. 2004; 37(4):610-3. DOI: 10.2144/04374ST06. View

4.
Medeiros-Neto G, Camargo R, Tomimori E . Approach to and treatment of goiters. Med Clin North Am. 2012; 96(2):351-68. DOI: 10.1016/j.mcna.2012.01.010. View

5.
Han Y, Gao L, Sun N, Zhang J, Zhang W, Zhou X . Effects of Kang-Jia-Wan, a Chinese medicinal herb officinal, on apoptosis induction in goiter of rats. J Ethnopharmacol. 2009; 122(3):533-40. DOI: 10.1016/j.jep.2009.01.023. View